NASDAQ
No price data available for this timeframe.
Celldex Therapeutics, Inc. (CLDX) has a revenue compound annual growth rate of -27.36% over 5 years and -12.15% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.